| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |